Rivaroxaban treatment for cancer-associated venous thromboembolism in a patient with heparin-induced thrombocytopenia: a case report

Low molecular weight heparin (LMWH) is the first-line therapy in acute cancer-associated venous thromboembolism (CAT). However, heparin-induced thrombocytopenia (HIT) is a life-threatening adverse drug reaction that occurs in anticoagulation therapy with LMWH. This article reports the case of a 66-y...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Ke-Jia, Yan, Yi-Dan, Liu, Yang-Xi, Xu, Jia-Bo, Cui, Min, Gu, Zhi-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797388/
https://www.ncbi.nlm.nih.gov/pubmed/35117000
http://dx.doi.org/10.21037/tcr.2019.09.55

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797388/
https://www.ncbi.nlm.nih.gov/pubmed/35117000
http://dx.doi.org/10.21037/tcr.2019.09.55

Ejemplares similares